| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/25/2009 | CN100463688C Ointment with aloe and other five medicinal herbs and its preparation method |
| 02/25/2009 | CN100463685C Medicine for treating acute secretory tympanitis and its preparing method |
| 02/25/2009 | CN100463683C Shuxiening injection preparation and processing thereof |
| 02/25/2009 | CN100463679C Clarithromycin soft capsule and its preparation |
| 02/25/2009 | CN100463678C Ifosfamide compositions for parenteral administration and a process for their preparation |
| 02/25/2009 | CN100463677C Preparation of nedaplatin freeze-dried powder injection |
| 02/25/2009 | CN100463676C Control releasing venlafaxine hydrochloride tablet and its preparation |
| 02/25/2009 | CN100463675C Soluble slow release external applied contraceptive |
| 02/25/2009 | CN100463674C Oral cavity quick dissolved film containing civeran and method for preparing the same |
| 02/25/2009 | CN100463673C Compound medicine release controlling film of chitosan, sodium alginate and gelatin and its preparing process |
| 02/25/2009 | CN100463672C Method for preparing large quantity of micro-capsule |
| 02/25/2009 | CN100463671C Vagina effervescent tablets containing callicarpa nudiflora and its preparation method |
| 02/25/2009 | CN100463670C Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 02/25/2009 | CN100463669C Self-emulsifying agent of compound artemether |
| 02/25/2009 | CN100463668C Reversibly hot gelified water soluble medicine composition |
| 02/24/2009 | US7495116 Phospholipid derivative |
| 02/24/2009 | US7495030 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 02/24/2009 | US7494980 administering a decapeptide of the sequence NH2-Iys-lys-val-val-phe-lys-val-lys-phe-lys-CONH2; biofilm formation inhibition; anticaries agent |
| 02/24/2009 | US7494824 Interactive system for presenting and eliminating substances |
| 02/24/2009 | US7494785 Recombinant subunit vaccine |
| 02/24/2009 | US7494690 Method of producing pharmaceuticals or food supplements comprising pigmented polymer coatings |
| 02/24/2009 | US7494669 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 02/24/2009 | US7494668 "auxiliary" granulate obtained by wet granulation of D-mannitol and maize starch gum in a high shear granulator, microcrystalline cellulose, a sweetener, a flavoring agent and a lubricant; pleasant taste and the absence of perceptible granules in the mouth |
| 02/24/2009 | US7494667 Blend of different acyl gellans with starch provides an excellent wet film with a high modulus and excellent strength and elongation; soft capsules have good sealability; replaces gelatin in capsules for no Bovine Spongiform Encephilitis (BSE) risk; use as dosage forms |
| 02/24/2009 | US7494666 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 02/24/2009 | US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome |
| 02/24/2009 | US7494643 Synergistic mixture of vismia and phytic acid |
| 02/24/2009 | CA2471338C Use of deoxypeganine for treating clinical depression |
| 02/24/2009 | CA2468370C Chronic, bolus administration of d-threo methylphenidate |
| 02/24/2009 | CA2462741C Dry liposomal pvp-iodine compositions |
| 02/24/2009 | CA2444208C Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| 02/24/2009 | CA2440333C Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| 02/24/2009 | CA2416109C Solid dose nanoparticulate compositions |
| 02/24/2009 | CA2394136C Bonded products and methods of fabrication therefor |
| 02/24/2009 | CA2390563C Apparatus and method for preparing microparticles using in-line solvent extraction |
| 02/24/2009 | CA2373962C Immediate release medicinal compositions for oral use |
| 02/24/2009 | CA2362888C Use of r-aryl propionic acids for producing medicaments to treat diseases in humans and animals, whereby said diseases can be therapeutically influenced by inhibiting the activation of nf-kb |
| 02/24/2009 | CA2354472C Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 02/24/2009 | CA2341297C Dosage form comprising liquid formulation |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2338605C Pliable and moldable polymeric delivery system for bioactive agents |
| 02/24/2009 | CA2334919C Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 02/24/2009 | CA2308462C Fibrin sealants or adhesives comprising a hyaluronic acid derivative material |
| 02/24/2009 | CA2264238C Galenic formula with extended release of milnacipran |
| 02/24/2009 | CA2188043C 7,11 disubstituted camptothecin derivatives, formulations containing such derivatives and their use |
| 02/24/2009 | CA2174556C Recombinant p53 adenovirus methods and compositions |
| 02/24/2009 | CA2152949C Vaccine preparations |
| 02/23/2009 | CA2716082A1 Process for preparing concentrated aqueous micellar solutions |
| 02/21/2009 | CA2638970A1 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/21/2009 | CA2638969A1 Methods for attaining enhanced sexual wellness using anhydrous compositions |
| 02/21/2009 | CA2638952A1 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/19/2009 | WO2009023819A2 Toll like receptor modulators |
| 02/19/2009 | WO2009023803A2 Modulated release formulation for the delivery of one or more medicaments |
| 02/19/2009 | WO2009023761A2 Pharmaceutical compositions comprising ropinirole |
| 02/19/2009 | WO2009023697A2 Hollow silica nanospheres and methods of making same |
| 02/19/2009 | WO2009023688A1 Inorganic coagulation accelerators for individuals taking platelet blockers or anticoagulants |
| 02/19/2009 | WO2009023672A2 Abuse resistant drugs, method of use and method of making |
| 02/19/2009 | WO2009023601A2 Apparatus and methods for treating epilepsy using convection-enhanced delivery |
| 02/19/2009 | WO2009023544A2 Dosage unit anion-exchange polymer pharmaceutical compositions |
| 02/19/2009 | WO2009023434A2 Method for stabilizing phenylephrine |
| 02/19/2009 | WO2009023030A1 Immediate release and sustained release ibuprofen dosing regimen |
| 02/19/2009 | WO2009023029A1 Gelatin-based coatings having improved durability |
| 02/19/2009 | WO2009023014A1 Emamectin compositions and methods |
| 02/19/2009 | WO2009023013A1 Praziquantel and cmetidine compositions and methods |
| 02/19/2009 | WO2009022934A1 Intranasal pharmaceutical compositions comprising succinic acid and methods thereof |
| 02/19/2009 | WO2009022933A1 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid |
| 02/19/2009 | WO2009022798A2 Self-microemulsifying drug delivery system composition containing coenzyme q10 and method for preparing the same |
| 02/19/2009 | WO2009022756A1 Diagnosis and treatment of ischemic disease |
| 02/19/2009 | WO2009022674A1 Medical composition containing rebamipide |
| 02/19/2009 | WO2009022670A1 Quickly disintegrating tablet |
| 02/19/2009 | WO2009022477A1 Norbornene polymers bearing biologically active substances bonded thereto, proces for production of the same and use thereof |
| 02/19/2009 | WO2009022355A1 Extended release compositions comprising mycophenolate sodium and processes thereof |
| 02/19/2009 | WO2009022354A2 Modified dosage forms of tacrolimus |
| 02/19/2009 | WO2009022308A2 Spray-drying process for the manufacture of dye-loaded particles |
| 02/19/2009 | WO2009022307A2 Dye-loaded particles |
| 02/19/2009 | WO2009022190A1 Delivery of drug combinations |
| 02/19/2009 | WO2009022174A2 Non-aggregating virus formulation |
| 02/19/2009 | WO2009022169A1 Solid valsartan composition |
| 02/19/2009 | WO2009021840A1 Injectable pharmaceutical formulation of taxoids |
| 02/19/2009 | WO2009021656A2 Tablet containing donepezile hydrochloride in amorphous form |
| 02/19/2009 | WO2009021558A1 Mixtures comprising pellitorin and uses thereof |
| 02/19/2009 | WO2009021377A1 Non-gelatin shell material of hard capsule and process for preparing thereof |
| 02/19/2009 | WO2009021357A1 Cooling agent composition and preparative method thereof |
| 02/19/2009 | WO2009021325A1 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 02/19/2009 | WO2009021286A1 Organosilica encapsulated nanoparticles |
| 02/19/2009 | WO2009006299A3 Multi-particulate systems |
| 02/19/2009 | WO2009005613A3 Stable non-disintegrating dosage forms and method of making same |
| 02/19/2009 | WO2009004440A3 Quick dissolve compositions of memantine hydrochloride |
| 02/19/2009 | WO2008157369A3 Use of taci-ig fusion protein such as atacicept for the manufacture of a medicament for treating lupus erythematosus |
| 02/19/2009 | WO2008155520A3 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
| 02/19/2009 | WO2008154043A3 Near-infrared responsive carbon nanostructures |
| 02/19/2009 | WO2008148967A3 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
| 02/19/2009 | WO2008144365A3 Method for making dry powder compositions containing ds-rna based on supercritical fluid technology |
| 02/19/2009 | WO2008140507A9 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 02/19/2009 | WO2008133908A3 Suspension formulations of insulinotropic peptides and uses thereof |
| 02/19/2009 | WO2008120181A4 A method of producing fast dissolving tablets |
| 02/19/2009 | WO2008112565A9 Method and composition for treating cancer |
| 02/19/2009 | WO2008052031A3 2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions |
| 02/19/2009 | WO2006030301A4 Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers |
| 02/19/2009 | US20090048584 Closed Loop Medicament Pump |